Literature DB >> 18334872

Real-time PCR quantification analysis of five mucosal transcripts in patients with Crohn's disease.

Anders Eriksson1, Eva Jennische, Carl-Fredrik Flach, Alberto Jorge, Stefan Lange.   

Abstract

OBJECTIVES: Crohn's disease has a genetic background. Onset of the clinical manifestations, however, is suggested to be triggered by environmental factors. Microarray analysis has shown that the expression of transcripts aldolase B, elafin, MST-1, simNIPhom and SLC6A14 are altered in patients with ulcerative colitis. The primary aim of this study was to explore the expressions of these five transcripts in macroscopically inflamed and noninflamed mucosa in patients with Crohn's disease.
METHODS: Mucosal specimens obtained from colon in consecutive patients with Crohn's disease (n=23) and controls (n=67) undergoing colonoscopy were analyzed using real-time PCR technique.
RESULTS: The expressions of the transcripts aldolase B, elafin, simNIPhom and SLC6A14 were increased, whereas the expression of MST-1 was decreased in noninflamed rectal mucosa in patients with Crohn's disease compared with controls. The expression of aldolase B was increased and the expressions of elafin and simNIPhom were decreased in inflamed colonic mucosa compared with noninflamed rectal mucosa in patients with Crohn's disease. No correlation, between the clinical activity of Crohn's disease (Mayo score <or=5 vs. >or=6) and transcript expression was detected.
CONCLUSION: The mucosal transcript pattern in Crohn's disease may, based on the known biological function of the transcripts, explain some of the typical features of Crohn's disease and indicate a possible pathophysiological role of microbes. Our results may thereby contribute to the understanding of the pathogenesis and manifestations of Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18334872     DOI: 10.1097/MEG.0b013e3282f3557c

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  4 in total

Review 1.  The future of molecular approaches to inflammatory bowel disease.

Authors:  Boyko Kabakchiev; Smita Halder; Mark S Silverberg
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 2.  The Na+/Cl--Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis.

Authors:  Mohd Omar F Sikder; Shengping Yang; Vadivel Ganapathy; Yangzom D Bhutia
Journal:  AAPS J       Date:  2017-12-04       Impact factor: 4.009

3.  Novel role of the serine protease inhibitor elafin in gluten-related disorders.

Authors:  Heather J Galipeau; Michelle Wiepjes; Jean-Paul Motta; Jessica D Schulz; Jennifer Jury; Jane M Natividad; Ines Pinto-Sanchez; Daniel Sinclair; Perrine Rousset; Rebeca Martin-Rosique; Luis Bermudez-Humaran; Jean Christophe Leroux; Joseph A Murray; Edgardo Smecuol; Julio C Bai; Nathalie Vergnolle; Philippe Langella; Elena F Verdu
Journal:  Am J Gastroenterol       Date:  2014-04-08       Impact factor: 10.864

Review 4.  Amino Acid Transporter SLC6A14 (ATB0,+) - A Target in Combined Anti-cancer Therapy.

Authors:  Katarzyna A Nałęcz
Journal:  Front Cell Dev Biol       Date:  2020-10-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.